ShopVision | $4,100,000 | (Sep 19, 2025)
Lake | $2,600,000 | (Sep 19, 2025)
Samara(US) | $34,000,000 | (Sep 19, 2025)
Certified by Founder
Lodge
Corsair Pharma
start up
United States
- Sunnyvale, California
- 22/09/2023
- Series B
- $23,000,000
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.
- Industry Pharmaceutical Manufacturing
- Website https://www.corsairpharma.com/
- LinkedIn https://www.linkedin.com/company/corsairpharma/about/
Sevaro | $39,000,000 | (Sep 19, 2025)
Catena Clearing | $5,000,000 | (Sep 19, 2025)
Hydrostor | $55,000,000 | (Sep 19, 2025)
Centari | $14,000,000 | (Sep 19, 2025)
Factor2 Energy | $9,100,000 | (Sep 19, 2025)
Terra Oleo | $3,100,000 | (Sep 19, 2025)
Phia | $8,000,000 | (Sep 19, 2025)
Vibranium Labs | $4,600,000 | (Sep 19, 2025)
Invisible Technologies | $100,000,000 | (Sep 18, 2025)